The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
Completed · Not applicable · Has a placebo group
Conditions studied: HIV Positive, Anal Condylomata, Anal Warts, HIV Infections
In brief
The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
Key facts
- Study ID
- NCT00941889
- Run by
- Washington University School of Medicine
- People needed
- 32
- Starts
- 2007-07-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2016-07-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥18 years of age;
- HIV positive status;
- CD4 > 200 and viral RNA < 400 on anti-retroviral therapy (HAART) or CD4 > 350 if not on HARRT;
- the presence of anal warts that require surgical excision/ablation.
You may not qualify if…
- CD4 < 200 and/or viral RNA > 400 on HAART or CD4 < 350 and not on HAART ;
- low burden of anal warts that would not require surgical excision/ablation;
- previous vaccinations against HPV or allergic reactions to any vaccine component;
- patients who are currently pregnant;
- patients with a previous diagnosis of anal cancer;
- patients who are incarcerated;
- patients who have taken immunomodulators (i.e. interferon, interleukin, corticosteroids, etc.) within the last 90 days;
- patients who have had an opportunistic infection in the last 90 days or who have another intercurrent illness that precludes their safe enrollment in this study;
- patients who, in the judgment of the investigators, are unlikely to adhere to the protocol, either because of a substance abuse or psychiatric diagnosis, or other factors that would affect compliance;
- failure to strictly comply with the vaccination schedule.
Where it is running
- Washington University in St. Louis, Section of Colon Rectal Surgery — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.